ARTICLE | Clinical News
AlloMap Molecular Expression Test regulatory update
August 16, 2010 7:00 AM UTC
The International Society for Heart and Lung Transplantation (ISHLT) recommended XDx's AlloMap Molecular Expression test for non-invasive monitoring of acute cellular rejection in patients between 6 m...